MiRNA-30a-mediated autophagy inhibition sensitizes renal cell carcinoma cells to sorafenib

Biochemical and Biophysical Research Communications

Volumn 459, Issue 2, 2015, Pages 234-239

  Zheng, Bing ^a,b   Zhu, Hua ^b   Gu, Donghua ^b   Pan, Xiaodong ^b   Qian, Lin ^b   Xue, Boxin ^a   Yang, Dongrong ^a   Zhou, Jundong ^c   Shan, Yuxi ^a  

^a SOOCHOW UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Beclin 1; Chemo sensitization; miRNA 30a; Renal cell carcinoma; Sorafenib

Indexed keywords

3 METHYALDENINE; AUTOPHAGY PROTEIN 5; BAFILOMYCIN A1; BECLIN 1; CHLOROQUINE; MICRORNA; MICRORNA 30A; PROTEIN P62; SMALL INTERFERING RNA; SORAFENIB; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; APOPTOSIS REGULATORY PROTEIN; ATG5 PROTEIN, HUMAN; BECN1 PROTEIN, HUMAN; CARBANILAMIDE DERIVATIVE; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MIRN30 MICRORNA, HUMAN; NICOTINAMIDE; RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG SENSITIZATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; LIGHT CHAIN; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UPREGULATION; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CARCINOMA, RENAL CELL; DRUG EFFECTS; DRUG RESISTANCE; GENE SILENCING; GENETICS; KIDNEY NEOPLASMS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; MALE; MEMBRANE PROTEINS; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NIACINAMIDE; PHENYLUREA COMPOUNDS; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84925497174     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.084     Document Type: Article

References (33)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 2014 9 29
2. S. Buti, M. Bersanelli, A. Sikokis, F. Maines, F. Facchinetti, E. Bria, A. Ardizzoni, G. Tortora, and F. Massari Chemotherapy in metastatic renal cell carcinoma today? A systematic review Anticancer Drugs 24 2013 535 554
3. H. Li, X. Jin, Z. Zhang, Y. Xing, and X. Kong Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells Cell. Biochem. Funct. 31 2013 427 433
4. R.K. Amaravadi, and C.B. Thompson The roles of therapy-induced autophagy and necrosis in cancer treatment Clin. Cancer Res. 13 2007 7271 7279
5. S. Bialik, and A. Kimchi Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development Adv. Exp. Med. Biol. 615 2008 177 200
6. D. Gozuacik, and A. Kimchi Autophagy as a cell death and tumor suppressor mechanism Oncogene 23 2004 2891 2906
7. B. Zheng, J.H. Mao, L. Qian, H. Zhu, D.H. Gu, X.D. Pan, F. Yi, and D.M. Ji Pre-clinical evaluation of AZD-2014, a novel mTORC1/2 dual inhibitor, against renal cell carcinoma Cancer Lett. 357 2015 468 475
8. H. Du, L. Guo, F. Fang, D. Chen, A.A. Sosunov, G.M. McKhann, Y. Yan, C. Wang, H. Zhang, J.D. Molkentin, F.J. Gunn-Moore, J.P. Vonsattel, O. Arancio, J.X. Chen, and S.D. Yan Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease Nat. Med. 14 2008 1097 1105
9. A.L. Huang, M.C. Ostrowski, D. Berard, and G.L. Hager Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus Cell 27 1981 245 255
10. S. Wach, E. Nolte, A. Theil, C. Stohr, T. T R, A. Hartmann, A. Ekici, B. Keck, H. Taubert, and B. Wullich MicroRNA profiles classify papillary renal cell carcinoma subtypes Br. J. Cancer 109 2013 714 722
11. L.L. Fu, X. Wen, J.K. Bao, and B. Liu MicroRNA-modulated autophagic signaling networks in cancer Int. J. Biochem. Cell. Biol. 44 2012 733 736
12. B. Gowrishankar, I. Ibragimova, Y. Zhou, M.J. Slifker, K. Devarajan, T. Al-Saleem, R.G. Uzzo, and P. Cairns MicroRNA expression signatures of stage, grade, and progression in clear cell RCC Cancer Biol. Ther. 15 2014 329 341
13. S.J. Clarke, G.P. McStay, and A.P. Halestrap Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A J. Biol. Chem. 277 2002 34793 34799
14. P.G. Sullivan, M.B. Thompson, and S.W. Scheff Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury Exp. Neurol. 160 1999 226 234
15. H. Zhu, H. Wu, X. Liu, B. Li, Y. Chen, X. Ren, C.G. Liu, and J.M. Yang Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells Autophagy 5 2009 816 823
16. R.J. Amato Chemotherapy for renal cell carcinoma Semin. Oncol. 27 2000 177 186
17. B. Ljungberg, N.C. Cowan, D.C. Hanbury, M. Hora, M.A. Kuczyk, A.S. Merseburger, J.J. Patard, P.F. Mulders, and I.C. Sinescu EAU guidelines on renal cell carcinoma: the 2010 update Eur. Urol. 58 2010 398 406
18. B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Negrier, C. Chevreau, E. Solska, A.A. Desai, F. Rolland, T. Demkow, T.E. Hutson, M. Gore, S. Freeman, B. Schwartz, M. Shan, R. Simantov, and R.M. Bukowski Sorafenib in advanced clear-cell renal-cell carcinoma N. Engl. J. Med. 356 2007 125 134
19. L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res. 66 2006 11851 11858
20. K. Zimmermann, A. Schmittel, U. Steiner, A.M. Asemissen, M. Knoedler, E. Thiel, K. Miller, and U. Keilholz Sunitinib treatment for patients with advanced clear-cell renal-cell carcinoma after progression on sorafenib Oncology 76 2009 350 354
21. Y.S. Chang, J. Adnane, P.A. Trail, J. Levy, A. Henderson, D. Xue, E. Bortolon, M. Ichetovkin, C. Chen, A. McNabola, D. Wilkie, C.A. Carter, I.C. Taylor, M. Lynch, and S. Wilhelm Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models Cancer Chemother. Pharmacol. 59 2007 561 574
22. M.J. Ryan, G. Johnson, J. Kirk, S.M. Fuerstenberg, R.A. Zager, and B. Torok-Storb HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney Kidney Int. 45 1994 48 57
23. M.J. Dehoux, R.P. van Beneden, L. Fernandez-Celemin, P.L. Lause, and J.P. Thissen Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection FEBS Lett. 544 2003 214 217
24. H. Persson, A. Kvist, J. Vallon-Christersson, P. Medstrand, A. Borg, and C. Rovira The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs Nat. Cell. Biol. 11 2009 1268 1271
25. Y. Yu, L. Yang, M. Zhao, S. Zhu, R. Kang, P. Vernon, D. Tang, and L. Cao Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells Leukemia 26 2012 1752 1760
26. T. Hamidi, C.E. Cano, D. Grasso, M.N. Garcia, M.J. Sandi, E.L. Calvo, J.C. Dagorn, G. Lomberk, R. Urrutia, S. Goruppi, A. Carracedo, G. Velasco, and J.L. Iovanna Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death Clin. Cancer Res. 18 2012 5234 5246
27. L.L. Fu, Y. Cheng, and B. Liu Beclin-1: autophagic regulator and therapeutic target in cancer Int. J. Biochem. Cell. Biol. 45 2013 921 924
28. J. Reyjal, K. Cormier, and S. Turcotte Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies Adv. Exp. Med. Biol. 772 2014 167 188
29. D.C. Rubinsztein, P. Codogno, and B. Levine Autophagy modulation as a potential therapeutic target for diverse diseases Nat. Rev. Drug Discov. 11 2012 709 730
30. G. Korkmaz, C. le Sage, K.A. Tekirdag, R. Agami, and D. Gozuacik miR-376b controls starvation and mTOR inhibition-related autophagy by targeting ATG4C and BECN1 Autophagy 8 2012 165 176
31. L.B. Frankel, J. Wen, M. Lees, M. Hoyer-Hansen, T. Farkas, A. Krogh, M. Jaattela, and A.H. Lund microRNA-101 is a potent inhibitor of autophagy EMBO J. 30 2011 4628 4641
32. P.O. Seglen, and P.B. Gordon 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes Proc. Natl. Acad. Sci. U. S. A. 79 1982 1889 1892
33. A. Yamamoto, Y. Tagawa, T. Yoshimori, Y. Moriyama, R. Masaki, and Y. Tashiro Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells Cell. Struct. Funct. 23 1998 33 42